Suppr超能文献

人类 AID 和 APOBEC3G 中序列特异性的决定因素。

Determinants of sequence-specificity within human AID and APOBEC3G.

机构信息

Department of Chemistry, Wayne State University, Detroit, MI 48202, USA.

出版信息

DNA Repair (Amst). 2010 May 4;9(5):579-87. doi: 10.1016/j.dnarep.2010.02.010. Epub 2010 Mar 24.

Abstract

Human APOBEC3G (A3G) and activation-induced deaminase (AID) belong to a family of DNA-cytosine deaminases. While A3G targets the last C in a run of C's, AID targets C in the consensus sequence WRC (W is A or T and R is a purine). Guided by the structures of the A3G carboxyl-terminal catalytic domain (A3G-CTD), we identified two potential regions (region 1 and region 2) that may interact with DNA and swapped the corresponding regions between a variant of A3G-CTD and AID. The resulting hybrids were expressed in Escherichia coli and two different genetic assays and a biochemical assay were used to determine the sequence selectivity of the hybrids in promoting C to T mutations. The results show that while the 10 amino acid region 2 of A3G was its principal sequence-specificity determinant, region 1 of A3G enhanced the target cytosine preference conferred by region 2. In contrast, neither of the two regions in AID individually or in combination were sufficient to confer the DNA sequence preference of this protein upon A3G. Instead, introduction of AID sequences in A3G relaxed the sequence-specificity of the latter protein. Our results show that the sequence selectivity of APOBEC family of enzymes is determined by at least two separate sequence segments and there may be additional regions of the protein involved in DNA sequence recognition.

摘要

人类 APOBEC3G(A3G)和激活诱导的脱氨酶(AID)属于一类 DNA-胞嘧啶脱氨酶。虽然 A3G 靶向 C 串中的最后一个 C,但 AID 靶向 WRC 中的 C(W 为 A 或 T,R 为嘌呤)。在 A3G 羧基末端催化结构域(A3G-CTD)的结构指导下,我们确定了两个可能与 DNA 相互作用的潜在区域(区域 1 和区域 2),并在 A3G-CTD 和 AID 的变体之间交换了相应的区域。所得杂种在大肠杆菌中表达,并使用两种不同的遗传测定和生化测定来确定杂种在促进 C 到 T 突变中的序列选择性。结果表明,虽然 A3G 的 10 个氨基酸的区域 2 是其主要的序列特异性决定因素,但 A3G 的区域 1 增强了区域 2 赋予的靶胞嘧啶偏好。相比之下,AID 中的两个区域单独或组合都不足以赋予该蛋白对 A3G 的 DNA 序列偏好。相反,AID 序列的引入使后者的蛋白质序列特异性放松。我们的结果表明,APOBEC 酶家族的序列选择性由至少两个独立的序列片段决定,并且可能还有其他区域的蛋白质参与 DNA 序列识别。

相似文献

1
Determinants of sequence-specificity within human AID and APOBEC3G.
DNA Repair (Amst). 2010 May 4;9(5):579-87. doi: 10.1016/j.dnarep.2010.02.010. Epub 2010 Mar 24.
2
Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
J Biol Chem. 2010 Dec 24;285(52):40956-64. doi: 10.1074/jbc.M110.177402. Epub 2010 Oct 6.
3
An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.
J Mol Biol. 2009 Jun 26;389(5):819-32. doi: 10.1016/j.jmb.2009.04.031. Epub 2009 Apr 21.
4
Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
J Biol Chem. 2017 Aug 11;292(32):13459-13479. doi: 10.1074/jbc.M116.760637. Epub 2017 Jun 21.
5
Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
PLoS One. 2011;6(9):e24848. doi: 10.1371/journal.pone.0024848. Epub 2011 Sep 15.
7
RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
PLoS Pathog. 2009 Mar;5(3):e1000330. doi: 10.1371/journal.ppat.1000330. Epub 2009 Mar 6.
8
Dissecting APOBEC3G substrate specificity by nucleoside analog interference.
J Biol Chem. 2009 Mar 13;284(11):7047-58. doi: 10.1074/jbc.M807258200. Epub 2009 Jan 9.
9
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.
Nat Struct Mol Biol. 2008 Nov;15(11):1184-91. doi: 10.1038/nsmb.1497. Epub 2008 Oct 5.
10
The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.
J Mol Biol. 2013 Nov 15;425(22):4442-54. doi: 10.1016/j.jmb.2013.07.040. Epub 2013 Aug 11.

引用本文的文献

2
DNA hairpin base-flipping dynamics drives APOBEC3A recognition and selectivity.
Phys Chem Chem Phys. 2025 May 15. doi: 10.1039/d5cp00321k.
3
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.
Int J Mol Sci. 2025 Feb 12;26(4):1561. doi: 10.3390/ijms26041561.
4
APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy.
Mol Ther Oncol. 2024 Sep 10;32(4):200873. doi: 10.1016/j.omton.2024.200873. eCollection 2024 Dec 19.
5
An adenine base editor variant expands context compatibility.
Nat Biotechnol. 2024 Sep;42(9):1442-1453. doi: 10.1038/s41587-023-01994-3. Epub 2024 Jan 2.
6
Engineering of cytosine base editors with DNA damage minimization and editing scope diversification.
Nucleic Acids Res. 2023 Nov 10;51(20):e105. doi: 10.1093/nar/gkad855.
7
APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels.
CRISPR J. 2023 Oct;6(5):430-446. doi: 10.1089/crispr.2023.0027. Epub 2023 Sep 6.
8
Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors.
J Cancer Res Clin Oncol. 2023 Jan;149(1):357-366. doi: 10.1007/s00432-022-04395-2. Epub 2022 Oct 12.
9
The current toolbox for APOBEC drug discovery.
Trends Pharmacol Sci. 2022 May;43(5):362-377. doi: 10.1016/j.tips.2022.02.007.
10
Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B.
ACS Pharmacol Transl Sci. 2021 Jul 19;4(4):1390-1407. doi: 10.1021/acsptsci.1c00091. eCollection 2021 Aug 13.

本文引用的文献

1
A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
J Biol Chem. 2009 Aug 21;284(34):22898-904. doi: 10.1074/jbc.M109.025536. Epub 2009 Jun 26.
2
AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity.
Nat Struct Mol Biol. 2009 Jul;16(7):769-76. doi: 10.1038/nsmb.1623. Epub 2009 Jun 21.
3
An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.
J Mol Biol. 2009 Jun 26;389(5):819-32. doi: 10.1016/j.jmb.2009.04.031. Epub 2009 Apr 21.
4
Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G.
EMBO J. 2009 Feb 18;28(4):440-51. doi: 10.1038/emboj.2008.290. Epub 2009 Jan 15.
5
Evolution of phosphorylation-dependent regulation of activation-induced cytidine deaminase.
Mol Cell. 2008 Oct 24;32(2):285-91. doi: 10.1016/j.molcel.2008.08.019.
6
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Nature. 2008 Nov 6;456(7218):121-4. doi: 10.1038/nature07357. Epub 2008 Oct 12.
7
Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Nature. 2008 Mar 6;452(7183):116-9. doi: 10.1038/nature06638. Epub 2008 Feb 20.
9
Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G.
FEBS Lett. 2007 Oct 2;581(24):4761-6. doi: 10.1016/j.febslet.2007.08.076. Epub 2007 Sep 7.
10
DNA deamination in immunity: AID in the context of its APOBEC relatives.
Adv Immunol. 2007;94:37-73. doi: 10.1016/S0065-2776(06)94002-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验